Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This multi-receptor activation differentiates retatrutide from monotherapy and dual-agonist compounds, positioning it as a significant research tool for investigating metabolic disorders
PubMed laboratory research record [PMID: 34530866] PubMed record related to this compound for laboratory literature review
Inositol-derived molecules (sometimes referred to as inositol phosphoglycans) appear to act as secondary messengers in insulin pathways, helping cells respond more effectively to insulins signal.15 21 In human trials, MI supplementation has been associated with improvements in insulin sensitivity, fasting glucose, and postprandial glucose handling in certain populations including people with insulin resistance and pregnant individuals at risk of gestational diabetes.7 22 23 Meta-analyses suggest a reduction in gestational diabetes incidence when inositol is used preventively, though authors consistently note the need for larger, higher-quality randomized trials before firm clinical recommendations can be made.9 24 25 26 Ovarian function and hormone signaling In ovarian tissue, MI plays a role in follicle-stimulating hormone (FSH) signaling and oocyte maturation.27 28 DCI, meanwhile, appears more involved in insulin-mediated androgen production.29 Because these roles differ, some researchers propose that the balance between MI and DCI may matter, particularly in polycystic ovary syndrome (PCOS).30 Clinical trials in people with PCOS have reported improvements in ovulation frequency, menstrual regularity, and some metabolic markers with inositol supplementation.2 31 However, systematic reviews emphasize that many studies are small, heterogeneous, and of variable quality, and that more rigorous trials are needed before drawing strong conclusions.3 17 Body weight and cardiometabolic markers Beyond glucose control, inositol has been studied for broader metabolic effects
10.1016/j.cmet.2017.06.015 Cell Metab
Average weight regain: 7% of total body weight by 12 months post-discontinuation , representing approximately two-thirds of the weight they had lost
W., da Silva, L., Maciel, G., Huguenin, A
US$ 25.22
US$ 24.71
US$ 25.07
US$ 22.93
